These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23977186)

  • 21. Intranasal Administration of Novel Chitosan Nanoparticle/DNA Complexes Induces Antibody Response to Hepatitis B Surface Antigen in Mice.
    Lebre F; Borchard G; Faneca H; Pedroso de Lima MC; Borges O
    Mol Pharm; 2016 Feb; 13(2):472-82. PubMed ID: 26651533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.
    Ye T; Yue Y; Fan X; Dong C; Xu W; Xiong S
    Vaccine; 2014 Jul; 32(35):4457-4465. PubMed ID: 24958702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses.
    Childers NK; Tong G; Mitchell S; Kirk K; Russell MW; Michalek SM
    Infect Immun; 1999 Feb; 67(2):618-23. PubMed ID: 9916067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats.
    Jia R; Guo JH; Fan MW; Bian Z; Chen Z; Peng B; Fan B
    Vaccine; 2004 Jun; 22(20):2511-6. PubMed ID: 15193375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface modified liposomes for nasal delivery of DNA vaccine.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Mehta A; Vyas SP
    Vaccine; 2008 Apr; 26(18):2225-33. PubMed ID: 18396362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
    Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ
    Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1.
    Batista MT; Ferreira EL; Pereira GS; Stafford P; Maeda DLNF; Rodrigues JF; Brady LJ; Johnston SA; Ferreira LCS; Ferreira RCC
    Vaccine; 2017 Dec; 35(52):7273-7282. PubMed ID: 29146379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.
    Su LK; Yu F; Li ZF; Zeng C; Xu QA; Fan MW
    Acta Pharmacol Sin; 2014 May; 35(5):592-8. PubMed ID: 24705100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents.
    Cao XX; Li YH; Ye QL; Hu X; Wang TF; Fan MW
    Hum Vaccin Immunother; 2017 Oct; 13(10):2332-2340. PubMed ID: 28759297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of immunogenic response and protection in model rats by CSTM nanoparticles anticaries DNA vaccine.
    Li H; Lu Y; Xiang J; Jiang H; Zhong Y; Lu Y
    Nanomedicine (Lond); 2016 Jun; 11(11):1407-16. PubMed ID: 27221078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
    Fan X; Yue Y; Xiong S
    Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of a targeted fusion DNA construct against dental caries.
    Xu QA; Yu F; Fan M; Bian Z; Guo J; Jia R; Chen Z; Peng B; Fan B
    Caries Res; 2005; 39(5):422-31. PubMed ID: 16110216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal immunization against dental caries with a Streptococcus mutans-enriched fimbrial preparation.
    Fontana M; Dunipace AJ; Stookey GK; Gregory RL
    Clin Diagn Lab Immunol; 1999 May; 6(3):405-9. PubMed ID: 10225844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dental caries vaccine: are we there yet?
    Patel M
    Lett Appl Microbiol; 2020 Jan; 70(1):2-12. PubMed ID: 31518435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced efficacy of CTLA-4 fusion anti-caries DNA vaccines in gnotobiotic hamsters.
    Zhang F; Li YH; Fan MW; Jia R; Xu QA; Guo JH; Yu F; Tian QW
    Acta Pharmacol Sin; 2007 Aug; 28(8):1236-42. PubMed ID: 17640488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits Campylobacter jejuni in a White Leghorn model.
    Huang JL; Yin YX; Pan ZM; Zhang G; Zhu AP; Liu XF; Jiao XA
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20936115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curdlan sulfate-
    Zhang S; Huang S; Lu L; Song X; Li P; Wang F
    Int J Nanomedicine; 2018; 13():2377-2394. PubMed ID: 29713168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flagellin-PAc Fusion Protein Inhibits Progression of Established Caries.
    Bao R; Yang JY; Sun Y; Zhou DH; Yang Y; Li YM; Cao Y; Xiao Y; Li W; Yu J; Zhao BL; Zhong MH; Yan HM
    J Dent Res; 2015 Jul; 94(7):955-60. PubMed ID: 25883108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of CTLA4 fusion anti-caries DNA vaccine in rabbits and monkeys.
    Jia R; Guo JH; Fan MW; Bian Z; Chen Z; Fan B; Yu F; Xu QA
    Vaccine; 2006 Jun; 24(24):5192-200. PubMed ID: 16675075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.